Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.3c01889 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Haobing Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Antineoplastic Agents, Lung Neoplasms, Photochemotherapy. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Science and Technology Foundation of Shenzhen City, Fonds der Chemischen Industrie, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Due to cell mutation and self-adaptation, the application of clinical drugs with early epidermal growth factor receptor (EGFR)-targeted inhibitors is severely limited. To overcome this limitation, herein, the synthesis and in-depth biological evaluation of an erlotinib-platinum(II) complex as an EGFR-targeted anticancer agent is reported. The metal complex is able to self-assemble inside an aqueous solution and readily form nanostructures with strong photophysical properties. While being poorly toxic toward healthy cells and upon treatment in the dark, the compound was able to induce a cytotoxic effect in the very low micromolar range upon irradiation against EGFR overexpressing (drug resistant) human lung cancer cells as well as multicellular tumor spheroids. Mechanistic insights revealed that the compound was able to selectively degrade the EGFR using the lysosomal degradation pathway upon generation of singlet oxygen at the EGFR. We are confident that this work will open new avenues for the treatment of EGFR-overexpressing tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Environmental Engineering, Shenzhen University, Shenzhen 518060, China.
- School of Pharmaceutical Science, Shenzhen Campus of Sun Yat-sen University, Shenzhen 518107, China.
- Faculty of Chemistry and Biochemistry, Ruhr-University Bochum, Bochum 44780, Germany.
ORCID-Profile: Johannes Karges, Pingyu Zhang, Huaiyi Huang
Förderung
- Science and Technology Foundation of Shenzhen City
- Fonds der Chemischen Industrie
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Lai, Y., Li, D., Karges, J., Zhang, P., & Huang, H. (2024). Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01889
Vancouver
Wang H, Lai Y, Li D, Karges J, Zhang P, Huang H. Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.3c01889
BibTeX
@article{Wang2024,
author = {Wang, Haobing and Lai, Yidan and Li, Dan and Karges, Johannes and Zhang, Pingyu and Huang, Huaiyi},
title = {Self-Assembly of Erlotinib-Platinum(II) Complexes for Epidermal Growth Factor Receptor-Targeted Photodynamic Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.3c01889}
}
EUVIMED